Joshua Tobias

1.9k total citations
53 papers, 1.4k citations indexed

About

Joshua Tobias is a scholar working on Endocrinology, Infectious Diseases and Immunology. According to data from OpenAlex, Joshua Tobias has authored 53 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Endocrinology, 22 papers in Infectious Diseases and 15 papers in Immunology. Recurrent topics in Joshua Tobias's work include Escherichia coli research studies (26 papers), Viral gastroenteritis research and epidemiology (19 papers) and Monoclonal and Polyclonal Antibodies Research (14 papers). Joshua Tobias is often cited by papers focused on Escherichia coli research studies (26 papers), Viral gastroenteritis research and epidemiology (19 papers) and Monoclonal and Polyclonal Antibodies Research (14 papers). Joshua Tobias collaborates with scholars based in Sweden, Austria and Serbia. Joshua Tobias's co-authors include Ann‐Mari Svennerholm, Michael Lebens, Jan Holmgren, Ursula Wiedermann, Philip C. Hanna, James M. Slauch, Michael J. Mahan, John J. Mekalanos, R. John Collier and Susann Teneberg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Cancer Research.

In The Last Decade

Joshua Tobias

51 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joshua Tobias Sweden	23	646	604	297	289	198	53	1.4k
Armando Navarro Mexico	21	931 1.4×	586 1.0×	587 2.0×	319 1.1×	419 2.1×	90	2.1k
Timothy J. Wells Australia	19	484 0.7×	266 0.4×	313 1.1×	408 1.4×	183 0.9×	42	1.4k
Michael Lebens Sweden	27	826 1.3×	472 0.8×	756 2.5×	528 1.8×	145 0.7×	63	2.0k
Simona Rondini Italy	27	519 0.8×	820 1.4×	211 0.7×	293 1.0×	484 2.4×	47	1.7k
Maria Mavris France	17	546 0.8×	325 0.5×	405 1.4×	387 1.3×	124 0.6×	22	1.5k
Quanming Zou China	25	270 0.4×	558 0.9×	706 2.4×	798 2.8×	87 0.4×	94	2.2k
Taufiqur Rahman Bhuiyan Bangladesh	26	830 1.3×	666 1.1×	423 1.4×	260 0.9×	185 0.9×	108	1.8k
Michael J. Darsley United States	25	449 0.7×	492 0.8×	210 0.7×	388 1.3×	166 0.8×	36	1.2k
Yoshio Ichinose Japan	16	443 0.7×	217 0.4×	241 0.8×	206 0.7×	122 0.6×	67	1.1k
Cristina Alaimo Switzerland	16	356 0.6×	378 0.6×	70 0.2×	346 1.2×	76 0.4×	19	985

Countries citing papers authored by Joshua Tobias

Since Specialization

Citations

This map shows the geographic impact of Joshua Tobias's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joshua Tobias with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joshua Tobias more than expected).

Fields of papers citing papers by Joshua Tobias

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joshua Tobias. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joshua Tobias. The network helps show where Joshua Tobias may publish in the future.

Co-authorship network of co-authors of Joshua Tobias

This figure shows the co-authorship network connecting the top 25 collaborators of Joshua Tobias. A scholar is included among the top collaborators of Joshua Tobias based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joshua Tobias. Joshua Tobias is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tobias, Joshua, Michael Kundi, Erika Garner‐Spitzer, et al.. (2024). Abstract CT215: Frontline vaccination with the B-cell peptide compound HER-Vaxx (IMU-131), combined with standard-of-care chemotherapy induces high levels of HER2-specific antibodies mediating ADCC and intracellular phosphorylation inhibition resulting in overall survival benefit in patients with HER2+ metastatic or advanced gastric/GEJ adenocarcinoma - Final results from Phase II/HERIZON study. Cancer Research. 84(7_Supplement). CT215–CT215. 1 indexed citations

Tobias, Joshua, et al.. (2023). Cultural safe healthcare initiatives, implementations, and recommendations, for Indigenous peoples of Canada: a systematic review. 11(1).

Tobias, Joshua, Sandra Högler, Yee Chao, et al.. (2023). Preclinical and Clinical Observations Implying Combination Therapy to Enhance the Efficacy of the Her-2/neu B-Cell Peptide-Based Vaccine HER-Vaxx and to Prevent Immune Evasion. International Journal of Molecular Sciences. 25(1). 287–287. 1 indexed citations

Tobias, Joshua, et al.. (2023). Cultural safe healthcare initiatives, implementations, and recommendations, for Indigenous peoples of Canada: a systematic review. 12(1). 1 indexed citations

Ede, Nicholas J., Anthony J. Good, Joshua Tobias, et al.. (2022). Development of the B cell cancer vaccine HER-vaxx for the treatment of her-2 expressing cancers. Frontiers in Oncology. 12. 939356–939356. 6 indexed citations

Tobias, Joshua, et al.. (2022). 1676P Active immunization with a multi-peptide B cell vaccine, targeting trastuzumab and pertuzumab binding sites, prevents the formation of HER-2/neu expressing lung metastases. Annals of Oncology. 33. S1309–S1309. 1 indexed citations

Tobias, Joshua, Claire Battin, Annika De Sousa Linhares, et al.. (2020). A New Strategy Toward B Cell-Based Cancer Vaccines by Active Immunization With Mimotopes of Immune Checkpoint Inhibitors. Frontiers in Immunology. 11. 895–895. 24 indexed citations

Stojanović, Marijana, Emilija Marinković, Joshua Tobias, et al.. (2020). Cross-Reactive Effects of Vaccines: Heterologous Immunity between Tetanus and Chlamydia. Vaccines. 8(4). 719–719. 3 indexed citations

Davitt, Christopher J.H., Stéphanie Longet, Aqel Albutti, et al.. (2019). Alpha-galactosylceramide enhances mucosal immunity to oral whole-cell cholera vaccines. Mucosal Immunology. 12(4). 1055–1064. 19 indexed citations

10.

Mentzer, Astrid von, Joshua Tobias, Gudrun Wiklund, et al.. (2017). Identification and characterization of the novel colonization factor CS30 based on whole genome sequencing in enterotoxigenic Escherichia coli (ETEC). Scientific Reports. 7(1). 12514–12514. 24 indexed citations

11.

Tobias, Joshua, Joanna Jasińska, Karin Baier, et al.. (2017). Enhanced and long term immunogenicity of a Her-2/neu multi-epitope vaccine conjugated to the carrier CRM197 in conjunction with the adjuvant Montanide. BMC Cancer. 17(1). 118–118. 29 indexed citations

12.

Longet, Stéphanie, Joshua Tobias, Mónica Rosa, et al.. (2017). Thermostability of the coating, antigen and immunostimulator in an adjuvanted oral capsule vaccine formulation. International Journal of Pharmaceutics. 534(1-2). 60–70. 6 indexed citations

13.

Holmgren, Jan, Louis Bourgeois, Nils Carlin, et al.. (2013). Development and preclinical evaluation of safety and immunogenicity of an oral ETEC vaccine containing inactivated E. coli bacteria overexpressing colonization factors CFA/I, CS3, CS5 and CS6 combined with a hybrid LT/CT B subunit antigen, administered alone and together with dmLT adjuvant. Vaccine. 31(20). 2457–2464. 107 indexed citations

14.

Lundgren, Anna, Susannah Leach, Joshua Tobias, et al.. (2013). Clinical trial to evaluate safety and immunogenicity of an oral inactivated enterotoxigenic Escherichia coli prototype vaccine containing CFA/I overexpressing bacteria and recombinantly produced LTB/CTB hybrid protein. Vaccine. 31(8). 1163–1170. 44 indexed citations

15.

Tobias, Joshua & Ann‐Mari Svennerholm. (2012). Strategies to overexpress enterotoxigenic Escherichia coli (ETEC) colonization factors for the construction of oral whole-cell inactivated ETEC vaccine candidates. Applied Microbiology and Biotechnology. 93(6). 2291–2300. 31 indexed citations

16.

Tobias, Joshua, Ann‐Mari Svennerholm, Nils Carlin, Michael Lebens, & Jan Holmgren. (2011). Construction of a non-toxigenic Escherichia coli oral vaccine strain expressing large amounts of CS6 and inducing strong intestinal and serum anti-CS6 antibody responses in mice. Vaccine. 29(48). 8863–8869. 24 indexed citations

17.

Cohen, Dani, Joshua Tobias, A. Spungin‐Bialik, et al.. (2010). Phenotypic Characteristics of Enterotoxigenic Escherichia coli Associated with Acute Diarrhea Among Israeli Young Adults. Foodborne Pathogens and Disease. 7(10). 1159–1164. 8 indexed citations

18.

Tobias, Joshua, Ann‐Mari Svennerholm, Jan Holmgren, & Michael Lebens. (2010). Construction and expression of immunogenic hybrid enterotoxigenic Escherichia coli CFA/I and CS2 colonization fimbriae for use in vaccines. Applied Microbiology and Biotechnology. 87(4). 1355–1365. 17 indexed citations

19.

Rendi‐Wagner, Pamela, Joshua Tobias, Larisa Moerman, et al.. (2010). The seroepidemiology of Bordetella pertussis in Israel—Estimate of incidence of infection. Vaccine. 28(19). 3285–3290. 59 indexed citations

20.

Tobias, Joshua, et al.. (2008). Role of different genes in the CS6 operon for surface expression of Enterotoxigenic Escherichia coli colonization factor CS6. Vaccine. 26(42). 5373–5380. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact